In the context of inflammatory breast cancer (IBC), a reduction in LCN2 expression was found to markedly suppress tumor growth, invasion, and metastatic spread to the brain in both in vitro and in vivo studies (38). This evidence concerns the gene LCN2 and inflammatory breast carcinoma.